IP Library Granted Patent US 7,763,432
Granted Patent B2
US 7,763,432 · App. 11/552,454 · Granted Jul 27, 2010

Compositions and methods for early pregnancy diagnosis

Assignee: The Curators of the University of Missouri
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,763,432
App. No.
11/552,454
Granted
Jul 27, 2010
Kind
B2
Abstract

Pregnancy-associated glycoproteins (PAGs) are structurally related to the pepsins, thought to be restricted to the hoofed (ungulate) mammals and characterized by being expressed specifically in the outer epithelial cell layer (chorion/trophectoderm) of the placenta. By cloning expressed genes from ovine and bovine placental cDNA libraries, the inventors estimate that cattle, sheep, and most probably all ruminant Artiodactyla, possess possibly 100 or more PAG genes, many of which are placentally expressed. The PAGs are highly diverse in sequence, with regions of hypervariability confined largely to surface-exposed loops. Selected PAG that are products of the invasive binucleate cells, expressed highly in early pregnancy at the time of trophoblast invasion and expressed weakly, if at all, in late gestation are useful in the early diagnosis of pregnancy. In a preferred embodiment, the invention relates to immunoassays for detecting these PAGs.

Claims (14)

1. A purified antibody that binds specifically to pregnancy associated antigen present early in pregnancy and undetectable at about two months post-partum, wherein the pregnancy associated antigen comprises BoPAG6 (SEQ ID NO:29).

2. A kit comprising:

(a) a purified antibody according to claim 1 ; and

(b) a suitable container means therefor.

3. The kit of claim 2 , further comprising a second antibody that binds immunologically to the same BoPAG as the purified antibody of claim 1 and a suitable container means therefor.

4. The kit of claim 2 , wherein said purified antibody is attached to a support.

5. The kit of claim 4 , wherein said support is a polystyrene plate, test tube, or dipstick.

6. The kit of claim 3 , wherein said second antibody comprises a detectable label.

7. The kit of claim 6 , wherein said detectable label is a fluorescent tag, biotin, a chemiluminescent tag, or an enzyme.

8. The kit of claim 7 , wherein said enzyme is alkaline phosphatase or horseradish peroxidase.

9. The purified antibody of claim 1 , wherein the antibody is a monoclonal antibody.

10. The purified antibody of claim 1 , wherein the antibody is from a hybridoma cell that secretes a monoclonal antibody that reacts immunologically with BoPAG6.

11. The purified antibody of claim 1 , wherein the antibody is a polyclonal antibody.

12. The kit of claim 2 , wherein the purified antibody is a monoclonal antibody.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 10, 2010
From: UNIVERSITY OF MISSOURI COLUMBIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024513/0796 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2006
From: ROBERTS, ROBERT MICHAEL; GREEN, JONATHAN ANDREW; XIE, SANCAI
To: THE CURATORS OF THE UNIVERSITY OF MISSOURI
Reel/Frame 018661/0822 →
Continuity (5)
Division 1065554700 · Sep 4, 2003
Continuation 0927316400 · Mar 19, 1999
Provisional Application 6007878300 · Mar 20, 1998
Provisional Application 6010618800 · Oct 28, 1998
Related Publication 20070166773A1 · Jul 19, 2007